Alumina as a filler for bone cement: a feasibility study

Bone cement is a critical material in orthopedic surgery, but its mechanical and thermal properties remain a challenge. Prior research has shown that pure PMMA bone cement has limitations in strength and heat generation during curing. No prior work had resolved how adding fillers might improve performance while maintaining biocompatibility. This gap motivated the exploration of composite materials. Researchers had not yet tested the effects of alumina as a filler in PMMA. The need for better mechanical properties and reduced thermal trauma to surrounding tissue is well established. Existing literature suggests that filler materials can alter cement behavior. However, the specific effects of alumina on PMMA’s compressive and tensile strengths were not clear. This study aimed to address those uncertainties.

This study aimed to evaluate the feasibility of using Alcoa A-10 alumina as a filler in PMMA bone cement. The researchers sought to determine if the composite material could improve mechanical properties and reduce heat generation. They also wanted to compare the composite with pure PMMA. The motivation came from the need for better-performing bone cement. Alumina was selected for its known mechanical strength and chemical stability. The study focused on compressive and tensile strength measurements. The researchers also examined the thermal behavior of the composite. They aimed to assess the material’s biocompatibility in a short-term in vivo model.

The researchers fabricated a composite of Alcoa A-10 alumina and finely ground PMMA beads. They calculated the optimal weight ratio based on powder densities and packing efficiency. The selected ratio was 65% PMMA to 35% alumina. They also prepared a control group using pure PMMA. Silane-treated alumina was used in a third composition for comparison. Cylindrical samples were made for mechanical testing. Compressive and tensile strengths were measured using standard protocols. The thermal profiles of both cements were recorded during curing. The materials were implanted in rabbits for one week to assess tissue response.

The pure PMMA had a compressive strength of 79.64 ± 13.0 MPa and a tensile strength of 6.69 ± 0.6 MPa. The 65%-35% PMMA-alumina composite showed a compressive strength of 83.17 ± 4.8 MPa and a tensile strength of 5.12 ± 0.3 MPa. The silane-treated composite had a compressive strength of 71.52 ± 8.6 MPa and a tensile strength of 7.12 ± 0.5 MPa. The composite required 64% less monomer than pure PMMA. Both cements reached a peak temperature of 110–115°C during curing. The composite took 6.5 minutes longer to reach peak temperature. The pure PMMA and composite were implanted in rabbits for one week. Tissue response appeared acceptable for both compositions.

The researchers found that the 65%-35% PMMA-alumina composite showed comparable or slightly improved compressive strength compared to pure PMMA. The tensile strength was slightly lower in the composite. The reduced monomer requirement suggests potential benefits for tissue healing. The longer time to reach peak temperature may reduce thermal trauma. The silane-treated composite had lower compressive strength but higher tensile strength. The in vivo results suggest the composite is biocompatible. The authors propose that the composite could be a viable alternative to pure PMMA. They suggest further testing to confirm long-term performance.